Mentions
Extended reach
Total likes
Video views
AI synopsis
This collection reveals active, technically detailed discussions about the role of ACE2 and TMPRSS2 in SARS-CoV-2 entry, mentioning specific studies and patents that support ivermectin as a protease inhibitor, with words like 'knew,' 'recognized,' and 'cited' emphasizing the perceived importance and strategic implications for COVID-19 treatments and vaccine development.
Many discussions acknowledge the study's significance, with numerous mentions of protease inhibitors like ivermectin being shown to block viral entry, indicating broad support or recognition of the findings.
The discussions demonstrate high curiosity, often referencing specific mechanisms, patents, and the implications related to COVID-19 treatment options, reflecting strong engagement.
Participants frequently cite scientific studies, patents, and mechanisms, diving into detailed mechanistic explanations and sharing related medical and patent information, showing deep engagement.
The discussions highlight a profound belief that the study’s findings reveal critical information about antiviral strategies and potential pharmaceutical knowledge, suggesting high perceived impact.
Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkinleştiren TMPRSS2 enzimini bloke etmenin yoluyla ilgili bir yayın biraz önce yayınlandı. Bu hastalığı anlamada çok önemli bir adım https://t.co/bRClNj6fUd
Existem estudos pré-clínicos de inibidores dessa protease, como o mesilato de camostato, para o SARS-CoV2. https://t.co/k0LMkLCh1y
（ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさんいなかったので試せなかった。https://t.co/hqkM3fezg8
شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41qoAYOctl https://t.co/CqCd6HvA9C https://t.co/FbhpuTFvvH
Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_ https://t.co/0oSFG5BxdN https://t.co/eERzg2cwU9
Interview with Stefan Pöhlmann on how the attachment protein (spike) of the new coronavirus #SARSCoV2 uses the cellular attachment factor (ACE2) and the cellular protease TMPRSS2 for its activation. https://t.co/0oSFG5BxdN
This video provides a detailed 3D animation of SARS-CoV-2, illustrating its molecular organization, structure, and how it enters human cells by binding to ACE2 receptors and utilizing TMPRSS2 for activation. It also…
Göttingen infection researchers identify potential drug. The virus enters human cells via ACE2 and TMPRSS2, which can be blocked by an approved protease inhibitor, highlighting potential treatment strategies.
This video addresses the most frequently asked questions about the SARS-CoV-2 coronavirus. Topics include its structure, symptoms of COVID-19, prevention strategies, and current treatment options, as well as its origin…
Welcome to an update on SARS-CoV-2 infection, including key clinical features and outcomes. This video presents data from a study analyzing 1,099 confirmed COVID-19 cases, highlighting symptoms like fever and cough, and…
This video explores how nonsteroidal anti-inflammatory drugs (NSAIDs) like ibuprofen influence SARS-CoV-2 infection and immune response during COVID-19. Findings indicate NSAIDs lower inflammation and antibody…
This video explores how SARS-CoV-2 enters human cells by binding to ACE2 and utilizing TMPRSS2, and how a clinically proven protease inhibitor can block this process, highlighting potential treatment options.
ACEIs, ARBs, NSAIDs, acetaminophen, and steroids in COVID-19 treatment are analyzed, focusing on their effects on the cardiovascular system and symptom management, with insights from recent clinical studies and…
In the past two weeks, warnings and misinformation concerning COVID-19 and NSAID use have been spreading. This video explores the connection between COVID-19, acute kidney injury, and the effects of Angiotensin Receptor…
SARS-CoV-2 enters human cells by binding to the ACE2 receptor and relies on the TMPRSS2 enzyme for spike protein activation. A clinically approved TMPRSS2 inhibitor can block viral entry, highlighting potential…
I had a really cursed merch idea at work today... :3c
This is horrible.
I would too
今週は株投資で15万円儲かったので嬉しい
Welcome to Derry finally gets to clown town.
This is too true.
In kingdom 4335 I just dropped 2 pieces of crap into the Dragon's treasure.
あ、オメガバ、整いました これ書きます
Just seen the “look at all those chickens” on TikTok and wdym she’s a teenager already
newrepublic.com/post/203721/...
Did I have to go and check if I'd included that piece of information in the chapter instead of just thinking it? Yes, I did. (I had included it, phew!)
classic book
ゲーム時間を作るにはランをサボるしかねぇ！の気持ちで今日のランニングはサボります。 あと肉ちゃんにおかれましては明日のプロレスチケットを発券してくださいね。よろしくお願いします。
I report more accounts now vs just blocking. Report first, then block.
That was a pretty sweet puck flip for the first goal!
無職になれば全部解決すると思うんだけどな！！！！！！！！！！！！！！！！！！
なにしようかねー
oh I missed you, please put more beer cans in me baby boy (as friends)
oh yea i got this vid with u in it too
thank you to the senseless perverts at gfl studios who gave a robot eyebags i love you forever
I’m above cringe millennial nostalgia gak, I follow the 120 Minutes and 80’s/90’s Sears Catalog content farms for the RIGHT, INTELLECTUAL reasons.
I gotta delete this app and disappear from the interwebs I fear
Biden, Harris and more than a few Democrats in Congress bankrolled and green lit Israel's genocide. They're all accessories to mass murder. But that's not why Harris lost. White people elected Trump because they stupidly refused to vote for a black woman.
机周りを移動させるのもありだがコードの場所がな
We looked at Boxer’s fracture ED visits on holidays. The worst was Easter.
Hitler was a HUGE disaster. Trump is the SAME disaster.
Repost with an anime that you love :3
uwaaaaaaaaa~~
Pinned skeets all the way down
ガソリン2週間で10円安くなっててうれしい
LOL Oh that's VERY funny.
Burnie is fucking hilarious! He plays like a boss character, and because Scorch is not a typical status effect, not even bosses resist it, meaning he melts through everything in seconds if you spam his S-Craft.
어뜩해 저거 페이커 이기면 트위터서 페이커 차단하는거 아냐?
만 두 .
#USA
OOOP. I got blocked?
사랑을 받아들인 모습 아름답다
Sounds like our house
She is so giving
That's a lot of stuffing! (Laudatory)
youtu.be/ANE4GYHit1U?...
Trump is ruled frivolous. Of course we all know this already,now it is legal.
This ⬆️ ⬆️ ⬆️
Aaaabboootttt!
Do you guys wanna see my boobs
Check out those edges! This color shifting pigment changes depending on the angle that you are viewing it from. The spiderwebs are reflective and turn from light gray to rainbow when strong light hits it! I have several new color-shifting pigments, they will be posted soon! #goth #alt #etsy
Yes, that Chevron.
Tのむちゃんとの結婚生活を知ったZからの呼ばれ方第一位 エロ親父
Oh they ready ready i love it.
Unfortunately I am not able to participate in this meme thread
So, in other words, she is a nobody. My lunar landing module would not get anywhere near that face. I am worried about the rebound. 2 wrongs don't make a right. Sometimes a court order is required, and then ignored. So that way definitely does not make it right.
That’s wild. I’m not coordinating, just tapped into the collective consciousness
学マスのライブ行く以上逃れられん模様
コーヒーが！ステンレスのグラス？に入ってるので冷めません！猫舌つらい
first edit was crazy
To be fair, some were tasked revising the Epstein files... oops, did I just say that out loud ? Reviewing the Epstein files..
www.koin.com/news/portlan... The money for these shelters should have gone to housing, housing assistance, eviction assistance, and creating a more robust and sustainable service provider system that also pays staff well.
i tried to make a remix of it, emphasis on "tried" www.youtube.com/watch?v=DTLI...
This is not dissimilar to my toiletries/cosmetics cupboard. We need to normalise skin care for men, and not mock it.
@dagnificent.bsky.social let’s make atlas shrugged with a model trainset and pez dispensers as all the characters but we’ll keep it in a vault until the book goes into the public domain in 2052
And still looking amazing and hopping to the next thing and striving n surviving? Yeag, Magik!
こんだけ翻訳ツールの発達した現代でもやっぱ助動詞の違いで意味が変わる日本語話者だから英語も自身の感性で申し分なくわかりて〜！！！ので今日も頑張って勉強します！！！Duolingoとラジオ英会話いつもありがとう。
Noooooo Mr snuggins
hal
I really, really liked the ride. I never understood the allure of a big ass cadillac convertible until I started regularly driving the American southwest
あら……お大事にね。 昆布茶があったら、ぬるめに作るとあまり滲みないし粘膜の保護にもなって飲みやすくていいかも。 あと、生クリームとかバニラアイスとかも飲み込みやすいと思うよ。
Srsly tho A SERIOUS MAN is the best adaptation of Job.
#FrightClub If a broom falls in a dorm hallway and only one airhead dude is there to hear it, does it make noise?
Nessas horas jogar algo tipo BallxPit salva muito
I'm always in mood for kitties
I appreciate your positivity, Sarah! It’s been a while. Hope you’ve been well!
Tu commence tôt ta journée ?
yeah, I thought that was weird too
砂糖をふりかけます。 甘い、甘すぎる。 ペングペングズーのおせち shindanmaker.com/chart/110349... #shindanmaker #クソおせち shindanmaker.com/1103499
小田急に新しい「赤い電車」登場！ 目立つカラーリングに変更された理由とは 27日から運行開始 trafficnews.jp/post/609715 ……私はモハ１形(旧ロマンスカー)の継承のほうが喜ぶけどね
like a 9 volt! she thinks they're SO funny
I took the liberty of updating for accuracy.
2-in-1 lip plumper gloss. 12 shades, vegan formula, 12-hour hydration. Non-sticky high shine for fuller, glossier lips.
Wait. There’s Actually A Trump Healthcare Plan? open.substack.com/pub/statusku...
『うさギョロ!』まめもやし
Its pretty cool seeing how hyped the fans and the rest of the team gets whenever the walk-ons score.
DDって精神衛生上は良くて
for me these two are ʔelmāẓ, emphatic ẓ, and ḡ̇abb, crucially with an "emphatic" ḡ (if you want to take emphasis as a property of consonants) the author was aware of the ẓ in his ʔalmāẓ which makes it curious to me that he didn't mention it in <ḡabb>. does that mean his 'to gulp' is a plain [ɣæbb]?
Yep. The families of those two soldiers can thank him later.
só me meto com gente dodói mesmo, af amo
Thank you! His name is Seath and he is a tiny Yuan-ti
Why worried, isn't that a good thing for you?
youtu.be/l8QxQuy3be4?...
お疲れ様でした
@grok Ummm... What the fuck is this? ### Paper Details **Title:** SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor **Authors:** Markus Hoffmann, Hannah Kleine-Weber, Simon Schroeder, Nadine Krüger, Tanja Herrler, Sandra
Our starting point SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: Cell www.cell.com/cell/fulltex...
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: Cell https://t.co/VSdRtOBHBf
@jeanpaulcarce @corinne_lalo Pour vous faire changer d'avis alors. Voici l'étude qui donc : la protéine Spike est une protéine virale. C'est la protéine membranaire vital clé qui permet d'entrer dans les cellules humaines https://t.co/IkMPaEzJc2
@BreakingNewsFi2 @LaurenBjork @GervenRose @DrNeilStone How SARS-CoV-2 Infects Human Cells
RT @Sabisteb: @DrSynthetiks @betabetula @TiloJung @VaccineMole Drostern war derjenige, der die Bindung des Spike an ACE2 publiziert hat: ht…
RT @Sabisteb: @DrSynthetiks @betabetula @TiloJung @VaccineMole Drostern war derjenige, der die Bindung des Spike an ACE2 publiziert hat: ht…
@DrSynthetiks @betabetula @TiloJung @VaccineMole Drostern war derjenige, der die Bindung des Spike an ACE2 publiziert hat: https://t.co/vfJNqPOoB0 https://t.co/IXWJ6cAusB
RT @FrauHodl: @p3likaan Warum ist Marcel A. Müller von der Charité Berlin auch am Martsinovsky Institute of Medical Parasitology, Tropical…
RT @FrauHodl: @p3likaan Warum ist Marcel A. Müller von der Charité Berlin auch am Martsinovsky Institute of Medical Parasitology, Tropical…
RT @FrauHodl: @p3likaan Warum ist Marcel A. Müller von der Charité Berlin auch am Martsinovsky Institute of Medical Parasitology, Tropical…
@p3likaan Warum ist Marcel A. Müller von der Charité Berlin auch am Martsinovsky Institute of Medical Parasitology, Tropical and Vector Borne Diseases, Sechenov University in Moscow, Russia? April 16, 2020 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically https://t.co/XEBI4kAYzF
@McAlpineLabYale Too simple. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 .. An inventory of ACE2 and TMPRSS2 and organs is too long for X. Once infected cells must die or be dismantled by the immune system to clear the virus from an individual. Audit normal life cycles vs infection 4 each.
#Sars https://t.co/9oXo6yw5G9
RT @sophsweet: @DiedSuddenly_ https://t.co/P2O988eYTL I wonder what TMPRSS2 is. SARS-Cov2 cell entry is blocked by protease inhibitor, ie i…
RT @GauteNilsen:
@overcatbe @DrEvaBernat @quay_dr RFK Jr brought up this article too and was attacked by the Zionist for it. Here are the German and Chinese counterparts. https://t.co/rZYTvGlEjo https://t.co/Auxi77FntU
RT @jisukewizon: @4e574f363636 @asobinin_t @studiocorvo 病原性に関してどれだけ論文でてると思ってんの？https://t.co/8dYxFp6qND
@jisukewizon @asobinin_t @studiocorvo https://t.co/MZDUplFBBn ＞私たちの結果は、SARS-CoV-2とSARS-CoV感染の重要な共通点を明らかにし ｗｗ ウイルス粒子の発見論文でも無いのに 俺がこの論文を読んで どんな返信を期待してるの？ 犬にボール投げて持って帰ってきたぐらいの感情なんだけど
@4e574f363636 @asobinin_t @studiocorvo 病原性に関してどれだけ論文でてると思ってんの？https://t.co/8dYxFp6qND
@ProbioticFarmer @uTobian That's not something i know enough about to comment on. I'm referring to this: https://t.co/MFrdygcVYk which is in non-patent citations in this, which contains "recombinant proteins" added into the adenovirus vector https://t.co/P2O988er4d
This blog post by @PierreKory is very accessible to a lay person to understand the spike protein. After all check out this patent https://t.co/LLxroGtgDf then this article about protease inhibitors cited in patents. https://t.co/MFrdygcVYk cited in patent https://t.co/P2O988er4d https://t.co/x4pG8QAYmS
@liz_churchill10 Only the third time? I got a tweet removed for asking - yes asking - if Biden would ever be given Ivermectin. This article is cited in a patent for an adenovirus vector vaccine. https://t.co/MFrdygdtNS
@WashburneAlex @DrHermiz TMPRSS-2 binds to and cleaves the FCS at RRA ! S Markus Hoffmann et al., "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor," Cell, March 2020
@MJTruthUltra https://t.co/MFrdygcVYk protease inbhibitors block spike protein and cleave site required for covid cell entry. Cited in vaccine patents. They knew. https://t.co/P2O988er4d
@lawrie_dr Isn't ivermectin a protease inhbibitor? They cited protease inhbibitors as blocking cell entry, which the spike protein and cleavage site were needed for in vaccine patents in 2020. The expensive trials were laying a trail for the pharmaceutical industry. https://t.co/MFrdygcVYk
@CartlandDavid SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor is cited in a vaccine patent. https://t.co/MFrdygcVYk They knew protease inhbibitors worked against covid. https://t.co/P2O988er4d
@VigilantFox @joerogan Ivermectin is a protease inhibitor and in 2020, these were cited in patents for vaccine candidates for blocking cell entry. vaccine patent https://t.co/P2O988er4d cites "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor
RT @GauteNilsen:
@Martyupnorth_2 In vaccine patents there were articles citing protease inhibitors "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" https://t.co/uMh4RBSLXc
@DschlopesIsBack This is what is being suppressed on social media. In a patent for a vaccine, in non-patent citations is an article in a medical journal "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" #Ivermectin is a protease inhibitor https://t.co/G7eiguSFV2
This patent for a "Recombinant novel coronavirus vaccine using replication-deficient human adenovirus as vector" cites "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" This says a lot! Ivermectin is a protease inhibitor https://t.co/PwODUTMKuC
@AFLDSorg See this patent https://t.co/P2O988eYTL in non-patent citations is a link to an article about protease inhibitors, which means it was known that a protease inhibitor such as Ivermectin blocked the ACE2 and cleavage site TMPRSS2, used for SARS2 cell entry. https://t.co/MFrdygdtNS
@unhealthytruth @MdBreathe It really makes me wonder why vaccine lab work for patents like this https://t.co/P2O988eYTL cite medical articles about protease inhibitors from 5 March 2020 like https://t.co/MFrdygdtNS particularly when https://t.co/N6wajWzs24
@MdBreathe @COVIDSelect Why did patents for vaccines such as https://t.co/P2O988eYTL have a non-patent citation stating 5.3.20 "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" and smear Ivermectin, a protease inhibitor? https://t.co/MFrdygdtNS https://t.co/e2pUVopevh
@Inversionism They knew in 2020 ivermectin was a protease inhibitor and would block cell replication, which they added to patents for vaccines. https://t.co/MFrdygcVYk
@DiedSuddenly_ https://t.co/P2O988eYTL I wonder what TMPRSS2 is. SARS-Cov2 cell entry is blocked by protease inhibitor, ie ivermectin. They knew. https://t.co/MFrdygdtNS
@unhealthytruth I just get shadowbanned on here as I can show the patent, involvement and knowledge protease inhibitors block cell entry. https://t.co/P2O988eYTL Have a good browse around. https://t.co/MFrdygdtNS https://t.co/iMZgwPskCk
@DiedSuddenly_ @billmaher @joerogan Here is proof they were ready to block ivermectin by demanding "clinically proven" ie ability to profit from. https://t.co/MFrdygdtNS
@MLiamMcCollum @ComicDaveSmith @joerogan @ChrisCuomo https://t.co/MFrdygdtNS This is quoted in patents relating to covid vaccines.
When researching mRNA and chimp adenovirus vector vaccines before 2020 they identified protease inhibitorsto block cell entry. See patent: https://t.co/P2O988eYTL "non-patent citations" then https://t.co/MFrdygdtNS https://t.co/W9Tyq9avao https://t.co/yCPZWlbMp5
#Sars https://t.co/5l1ZgSZtJC
I'm now fascinated to know what ivermectin - or a protease inhititor - reveals about covid, Long Covid and the vaccine? In non-patent citations in this patent: https://t.co/P2O988er4d There's a link to an article about protease inhibitors https://t.co/MFrdygcVYk https://t.co/zAULykhhzX
RT @sophsweet: @lawrie_dr Did you ever see the hidden info from March 2020 showing that a protease inhibitor was recognised as a treatment…
@VigilantFox Interesting how this: https://t.co/YF6dYEkZA1 is a non-patent citation here: https://t.co/dwkNf5qbE2… Ivermectin is a protease inhibitor.
@MdBreathe @Walgreens Interesting how this: https://t.co/MFrdygcVYk is a non-patent citation here: https://t.co/P2O988er4d Ivermectin is a protease inhibitor.
RT @FrauHodl: @EdV1694 @ClareCraigPath @NickHudsonCT @DrJBhattacharya @53v3n0fn1n3 I agree with you and an additional reason is this April…
RT @sophsweet: @lawrie_dr Did you ever see the hidden info from March 2020 showing that a protease inhibitor was recognised as a treatment…
RT @FrauHodl: @EdV1694 @ClareCraigPath @NickHudsonCT @DrJBhattacharya @53v3n0fn1n3 I agree with you and an additional reason is this April…
RT @FrauHodl: @EdV1694 @ClareCraigPath @NickHudsonCT @DrJBhattacharya @53v3n0fn1n3 I agree with you and an additional reason is this April…
RT @FrauHodl: @EdV1694 @ClareCraigPath @NickHudsonCT @DrJBhattacharya @53v3n0fn1n3 I agree with you and an additional reason is this April…
RT @FrauHodl: @EdV1694 @ClareCraigPath @NickHudsonCT @DrJBhattacharya @53v3n0fn1n3 I agree with you and an additional reason is this April…
@EdV1694 @ClareCraigPath @NickHudsonCT @DrJBhattacharya @53v3n0fn1n3 I agree with you and an additional reason is this April 16, 2020 publication from Christian Drosten. Looks like specific foreknowledge of receptor binding activity. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor ➡️ https://t.co/CTIsZsM6Ko
Etc Etc #Sars https://t.co/HRraIGpS4O
RT @drkohilathas: SARS-CoV-2 enters cells by binding its spike protein to ACE2, and in order to do this successfully, the virus needs to pr…
RT @sophsweet: In this adenovirus vaccine patent, a protease inhibitor is recognised as a treatment. https://t.co/dwkNf5qbE2… Cites: https:…
In this adenovirus vaccine patent, a protease inhibitor is recognised as a treatment. https://t.co/dwkNf5qbE2… Cites: https://t.co/YF6dYEkZA1
@StAustellAdam @LeoKearse Adenovirus vaccine patent from 2020 cited medical paper on protease inhibitors (ivermectin is one) working against covid and SARS https://t.co/P2O988er4d article cited in patent https://t.co/MFrdygcVYk then Merck have patented a protease inhibitor https://t.co/nESMpaiefz
#Sars https://t.co/QO5rlqSbPU
@RebeccaWeisser Did you see this? Patent for adenovirus vector citing an article about how a protease inhibitor would work against covid/SARS https://t.co/dwkNf5qbE2… the article cited https://t.co/YF6dYEkZA1 then a patent from Merck for a protease inhibitor https://t.co/J3yhrzpGVP…
@DrSHankMD @DrSuneelDhand Did you see this? Patent for adenovirus vector citing an article about how a protease inhibitor would work against covid/SARS https://t.co/dwkNf5qJtA… the article cited https://t.co/YF6dYElxpz then a patent from Merck for a protease inhibitor https://t.co/J3yhrzqeLn…
@JayVarrone @DrSuneelDhand Did you see this? Patent for adenovirus vector citing an article about how a protease inhibitor would work against covid/SARS https://t.co/dwkNf5qJtA… the article cited https://t.co/YF6dYElxpz then a patent from Merck for a protease inhibitor https://t.co/J3yhrzqeLn…
Example of profiteering. Patent for adenovirus vector citing an article about how a protease inhibitor would work against covid/SARS https://t.co/dwkNf5qJtA… the article cited https://t.co/YF6dYElxpz then a patent from Merck for a protease inhibitor https://t.co/J3yhrzqeLn…
@GlobalHProject Did you see this? Patent for adenovirus vector citing an article about how a protease inhibitor would work against covid/SARS https://t.co/dwkNf5qJtA… the article cited https://t.co/YF6dYElxpz then a patent from Merck for a protease inhibitor https://t.co/J3yhrzqeLn…
@ProfTimNoakes Did you see this? Patent for adenovirus vector citing an article about how a protease inhibitor would work against covid/SARS https://t.co/dwkNf5qJtA… the article cited https://t.co/YF6dYElxpz then a patent from Merck for a protease inhibitor https://t.co/J3yhrzqeLn…
@GlobalHProject Did you see this? Patent for adenovirus vector citing an article about how a protease inhibitor would work against covid/SARS https://t.co/dwkNf5qJtA… the article cited https://t.co/YF6dYElxpz then a patent from Merck for a protease inhibitor https://t.co/J3yhrzqeLn…
@liz_churchill10 Did you see this? Patent for adenovirus vector citing an article about how a protease inhibitor would work against covid/SARS https://t.co/P2O988eYTL the article cited https://t.co/MFrdygdtNS then a patent from Merck for a protease inhibitor https://t.co/nESMpaiM57
@Covid19Critical @LTCTheresaLong @DocPeteChambers Academy of Military Medical Sciences patent for adenovirus, cites an article on protease inhibitors. https://t.co/P2O988er4d early 2020 https://t.co/MFrdygcVYk Now Merck have patented one https://t.co/nESMpaiefz
How many people died because Bill Gates funded the smearing, censorship and deplatforming of ivermectin? This adenovirus patent cites an article showing a protease inhibitor would stop covid and sars replication. https://t.co/P2O988eYTL article https://t.co/MFrdygdtNS
The same victim-playing voice of denial, self-contradiction and lies started in January 2020 with Pirbright Institute wanting to detract attention from its worldwide patents for coronavirus vaccines. https://t.co/7myveaPpzo See https://t.co/MFrdygcVYk #ProteaseInhibitor known https://t.co/RsV6nzQF2D
@unhealthytruth Have you seen this adenovirus patent actually recognises protease inhibitors as a treatment for covid and SARS? Patent https://t.co/P2O988eYTL cited article https://t.co/MFrdygdtNS
In this adenovirus vaccine patent, a protease inhibitor is recognised as a treatment. https://t.co/P2O988eYTL Cites: https://t.co/MFrdygdtNS https://t.co/1ur46xEknE https://t.co/SCtR5WnO1y
@lawrie_dr Did you ever see the hidden info from March 2020 showing that a protease inhibitor was recognised as a treatment for a coronavirus in a patent? This article https://t.co/MFrdygdtNS is cited in this patent https://t.co/P2O988eYTL in "non-patent citations" https://t.co/xoxNM5tx8b
@Thomas_Binder Hi Thomas, I've finally compiled a long blog about the Pirbright Patent intrigue. One amazing thing is a patent actually says a Protease Inhibitor (ivermectin) would work as an antiviral. https://t.co/P2O988er4d https://t.co/MFrdygcVYk my blog https://t.co/7myveaPpzo to be editd
@RipDaJUULz @KamelaToes @JenniferSey I discovered evidence via a coronavirus patent for a vaccine that a protease inhibitor (ivermectin) would work against covid cell replication, ACE2 receptor, spike protein. https://t.co/MFrdygcVYk Patent https://t.co/P2O988er4d cites above article.
#Sars https://t.co/aolpX3shwM
@evans_dawn41321 Ivermectin is a protease inhibitor. Protease inhibitor known about since March 2020. Mentioned in European patent: https://t.co/P2O988er4d Article cited: https://t.co/MFrdygcVYk
@ProfTimNoakes Ivermectin is a protease inhibitor. Protease inhibitor known about since March 2020. Mentioned in European patent: https://t.co/P2O988er4d Article cited: https://t.co/MFrdygcVYk
@nowoolovreyz @RachelNotley Ivermectin is a protease inhibitor. Protease inhibitor known about since March 2020. Mentioned in European patent: https://t.co/P2O988er4d Article cited: https://t.co/MFrdygcVYk
@VigilantFox Ivermectin is a protease inhibitor. Protease inhibitor known about since March 2020. Mentioned in European patent: https://t.co/P2O988er4d Article cited: https://t.co/MFrdygcVYk
@ChickadeeEJones Ivermectin is a protease inhibitor. Protease inhibitor known about since March 2020. Mentioned in European patent: https://t.co/P2O988er4d Article cited: https://t.co/MFrdygcVYk
@MdBreathe @Claude__Cat @MonthlySandwich Protease inhibitor known about since March 2020. Mentioned in European patent: https://t.co/P2O988er4d Article cited: https://t.co/MFrdygcVYk
@VigilantFox Protease inhibitor known about since March 2020. Mentioned in European patent: https://t.co/P2O988er4d Article cited: https://t.co/MFrdygcVYk
@DebraM2222 Article from 5 March 2020 recognising a protease inhibitor could treat covid and SARS. https://t.co/MFrdygcVYk This information is from a European patent for an adenovirus vector vaccine. https://t.co/P2O988er4d
@Johnincarlisle Hi John, did you ever see this article from 5 March 2020? It shows that a protease inhibitor could work as an anti-viral for covid and SARS-cov1. https://t.co/MFrdygcVYk Got it from here: https://t.co/VvlspM8gZi and mention of ChApOx1 here https://t.co/QwinrbXtnB
#Sars https://t.co/xrMoKUTiWB
SARS-CoV-2 enters cells by binding its spike protein to ACE2, and in order to do this successfully, the virus needs to prime its spike protein using an enzyme called transmembrane protease, serine 2 (TMPRSS2). https://t.co/Hn07vQGTuV
#Sars https://t.co/gbCEripywl
@rg_jill @drtaubraun Wow, this is a little awkward. The date on this is April 16, 2020 It’s become apparent that the government has literally done nothing but promote the jab https://t.co/uUI1lv6JWV
https://t.co/25CeTgTI3a
@Osiris74308060 @vi1111__ @WahnSager @FeuerruepelLP @SHomburg @rki_de Richtig ! Auch! Induziert wird es durch das Spikeprotein, welches Milliardenfach pro Impfung bei dir expremiert wird…https://t.co/7WwltMlg8J
RT @gemgegencorona: COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection https://t…
COVID-19: angiotensin-converting enzyme 2 (ACE2) expression and tissue susceptibility to SARS-CoV-2 infection https://t.co/8tZKooy7zr SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/1YugM0K9dJ
RT @KLDguitaramp: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/X…
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/X6LgS01GEj
@woodycartoons 1"A Novel Coronavirus from Patients with Pneumonia in China, 2019" published in The New England Journal of Medicine, February 2020: https://t.co/wdRWNqarSG 2"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" published in
https://t.co/EYhQ6Qerkk
https://t.co/ZfDo2YCptC
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/kyNZvDOqK0
@ANGELOF73572889 @MamaFrann HCQ useless against SARS CoV-2 because Spike is already cleaved by TMPRSS2 before it reaches the endosome. HCQ inhibition of cathepsin via prevention of endosome acidification is too little too late. But, you know, SCIENCE! https://t.co/pz877HrsUb
@sarahleispag @rmparmarsurat I trust the scientist who demonstrated in April 2020 that HCQ is useless at inhibiting SARS CoV-2 since Spike protein is already cleaved by TMPRSS2 before it reaches the endosomes. HCQ's prevention of acidification of endosomes is too little, too late. https://t.co/pz877HrsUb
@Locuste_ Comment fonctionne le remdé & a-t-il été choisi? Les pilotes de Discovery, Solidarity (sans bras camostat mesylate!) ont fait l'impasse sur la lecture de SARSCoV2 Cell Entry Depends on ACE2 & TMPRSS2 & Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/SO4xAPhRXm
#SarsCoV5G https://t.co/yRqtG6Y62x
Hoffmann M, Kleine-Weber H, Schroeder S, Krüger N, Herrler T, Erichsen S, Schiergens TS, Herrler G, Wu NH, Nitsche A, Müller MA (2020) SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell 181(2):271–280 #COVID19
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/WMxkXNLr6Q
1. Cell. 2020; doi: https://t.co/eKs3IE4jI7 2. Drug Dev Res. 2020; doi: https://t.co/xKgQCgVQcC 3. Ann Oncol. 2020; doi: https://t.co/Gl9Ka20Ce2 4. Cancer Res. 2009; doi: https://t.co/dNGHcprib9 5. Brain Res. 2002; doi: https://t.co/syVoZWYA9B https://t.co/CYHzqnXVse
@SteveMa85454815 @jordanbpeterson "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (PDF, 19 pages) https://t.co/fbt2oNd6jY
@dustyj @nypost This is from Cell Press: "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (PDF, 19 pages) https://t.co/fbt2oNd6jY
https://t.co/eCaMoRLkQp
https://t.co/excef8vQKH
@fourthdose doi: 10.1016/j.ijid.2021.04.043. https://t.co/pP52hOYlRu https://t.co/yOOpDGTbEk Yllä olevat liittyy ammoniumkloridiin. Hoffmann et al osoittaa, että inhibitio on hyvä, jos suora fuusio TMPRSS2:n kautta ei ole käytössä. Delta soluihin po. suoralla fuusiolla, omikron endodomeissa.
https://t.co/Rm0QHXTAKA
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: SARS-CoV-2 uses the SARS-CoV receptor ACE2 for host cell entry The spike protein of SARS-CoV-2 is primed by TMPRSS2 https://t.co/OKQrRlOYN7
RT @sloeginpsyop: @TheEliKlein Wait what? The OG SarsCov2 can definitely bind ACE2 and this has been known since the beginning. https://t.…
RT @sloeginpsyop: @TheEliKlein Wait what? The OG SarsCov2 can definitely bind ACE2 and this has been known since the beginning. https://t.…
@TheEliKlein Wait what? The OG SarsCov2 can definitely bind ACE2 and this has been known since the beginning. https://t.co/ZmvKv5UFHs
Corona zars CoV ...https://t.co/4LYuKAABNw
@SLT20201 "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (PDF, 19 pages) https://t.co/E7LYNY0XYf
SARS 8 https://t.co/dJHt7YXrWH
SARS https://t.co/DYHogNiyzS
@MdTeryn @egeehr @richardursomd So the theory is SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by Protease Inhibitors, in studies IVM scored the highests and has the most studies and best safety data profile. Pfizer's Paxlovid is a bit weaker then IVM with no LT Saftey Data + Very Expen$ive $
SARS https://t.co/zvSKzQLaWL
RT @SantasTavern: "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (PDF, 19 pag…
"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (PDF, 19 pages) https://t.co/E7LYNY0XYf
SARS https://t.co/0pZYu4wnvA
Everyday Same chaff news nowheather net or tv....heynow! https://t.co/99xYG1aieM
@replouiegohmert "Ivermectin Docks to the SARS-CoV-2 Spike Receptor-binding Domain Attached to ACE2" https://t.co/TdXmVZZmZI "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (PDF file) https://t.co/E7LYNY0XYf
@BeatrootB @replouiegohmert https://t.co/ERHAhRBbSm https://t.co/6Hxcmq9mGw https://t.co/aseRzM4FLf https://t.co/R1RAtw5DMB "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (PDF file) https://t.co/E7LYNY0XYf
@SmilesCat @P8R1OT_REDUX @AmerMedicalAssn The @US_FDA is spreading dangerous lies about ivermectin. Ask them why. "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" (PDF file) https://t.co/E7LYNY0XYf
#Sars https://t.co/vWIPzV49lw
The sars cv2 structure animation https://t.co/TzjTaOKRhU
https://t.co/pKBXBplOkf
SARS https://t.co/qJjiFb7wUM
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/LQa8tbwyV2
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/GlWIB9d3kE
@uMarhobane One thing I forgot to mention is this paper cited is legit: https://t.co/4yP0uDgh0h Cell is a top journal in molecular biology, not far off from Nature. This is a widely cited paper from last year elucidating the ACE2 mechanism. It just makes no mention of Ivermectin.
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a ... https://t.co/CVGA7tpwto
書記が論文読むだけ#225 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease @suzusyoki #note https://t.co/idYb73lqNK
Acute respiratory distress syndrome (ARDS) begins a few days later. For more information watch this video: Must Watch :- https://t.co/ZwjUUjBkth
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/GlWIB9d3kE
#SARS 12 https://t.co/b8hgJ4gL2d
#SARS https://t.co/C8YBEo5gQG
#SARS 10 https://t.co/C2ebtbqbwg
@CExercicio @daviusddl @AnaCarolPecanha @SamirMithqal O estudo de Manaus ainda citou como referência um artigo que responde a sua questão em relação ao mecanismo: https://t.co/usqDAu6RVz Chegou a ler???
SARS 2 YouTube Images 9 https://t.co/5pgJ90YEPa
@ANiSH1968 @DailyMailUK SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 binding vector.
@profcabarros @OmarAzizSenador Segue o estudo alemão mencionado então, já que o argumento do envenenamento do poço do bolsonarismo te dominou. Nele mostra que o SARSCOV-02 entra por outra via nas células respiratórias o que explica pq a HCQ não funciona nos Estudos com rigor científico. https://t.co/iiMEgnj1vI
Tu viviste Tu gran momento de vida incógnita, quedando sobre el refugio de la protección de la mascarilla, protegiéndote de enfermedades y viviendo la parálisis de silencio , que cambio al mundo , poniendo otra gran dimensión de vivir ...! https://t.co/CaonkCWsLq
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/AkylndMjXD
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/6zcnTm636s
SARS 2 Youtube Images 8 https://t.co/LqaQwIghjX
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor Markus Hoffmann, Christian Drosten, et al. APRIL, 2020. This continues to haunt 1/5
S https://t.co/03KpdJkwCg
このペーパー否定されたの⁉ 知らんけど。 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/joGyZJJBHs
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/GlWIB9d3kE
https://t.co/98YqEGUhlE
https://t.co/5jsy6SY8VQ
@GregHuntMP SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease inhibitors are a class of antiviral drugs. Protease inhibitors prevent viral replication by selectively binding to viral proteases and blocking proteolytic cleavage of protein
RT @AnaCarolPecanha: Existem estudos pré-clínicos de inibidores dessa protease, como o mesilato de camostato, para o SARS-CoV2. https://t.…
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/WuWVo1Zwuf
RT @AnaCarolPecanha: Existem estudos pré-clínicos de inibidores dessa protease, como o mesilato de camostato, para o SARS-CoV2. https://t.…
RT @AnaCarolPecanha: Existem estudos pré-clínicos de inibidores dessa protease, como o mesilato de camostato, para o SARS-CoV2. https://t.…
RT @AnaCarolPecanha: Existem estudos pré-clínicos de inibidores dessa protease, como o mesilato de camostato, para o SARS-CoV2. https://t.…
Existem estudos pré-clínicos de inibidores dessa protease, como o mesilato de camostato, para o SARS-CoV2. https://t.co/k0LMkLCh1y
RT @yosoysusan: Qué pérdida de tiempo mundial y cuántos muertos nos podríamos haber ahorrado masticando chicles de nicotina... y con cualqu…
Qué pérdida de tiempo mundial y cuántos muertos nos podríamos haber ahorrado masticando chicles de nicotina... y con cualquier medicamento que inhiba la ECA2 y la TMPRSS2 ... Hombres, próstatas y Covid. La otra cerradura. https://t.co/2SIfy0hpFE
RT @dronita_de: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/sZj…
RT @dronita_de: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/sZj…
RT @dronita_de: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/sZj…
RT @dronita_de: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/sZj…
RT @dronita_de: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/sZj…
RT @dronita_de: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/sZj…
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/sZjRl2Yjgf #DHPSP
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/sZjRl2Yjgf
RT @mmw_lmw: #2020_ReCapMarch | #SARS_CoV_2 | Cell entry depends on ACE2 and TMPRSS2 | blocked by a clinically-proven #TMPRSS2_Protease_In…
RT @mmw_lmw: #2020_ReCapMarch | #SARS_CoV_2 | Cell entry depends on ACE2 and TMPRSS2 | blocked by a clinically-proven #TMPRSS2_Protease_In…
RT @mmw_lmw: #2020_ReCapMarch | #SARS_CoV_2 | Cell entry depends on ACE2 and TMPRSS2 | blocked by a clinically-proven #TMPRSS2_Protease_In…
#2020_ReCapMarch | #SARS_CoV_2 | Cell entry depends on ACE2 and TMPRSS2 | blocked by a clinically-proven #TMPRSS2_Protease_Inhibitor | Stefan Pöhlmann @DPZ_eu @CellCellPress https://t.co/nIrKxaKx8h https://t.co/AyV8U0QS4x
RT @__ice9: @assur153 The paper itself is about camostat mesylate, though. Given what appears to be an equivalent mechanism, I suspect tha…
@itsbirdemic @kittypurrzog @JeffreyASachs they don't have to demonstrate the relevance of TMPRSS2, it's an uncontroversial part of covid epidemiology https://t.co/HFeiql1vEX
Hoffmann M, Kleine-Weber H, Schroeder S, et al. SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor. Cell. 2020; 181: 271-280.e8. #SARSCoV2 #CellEntry #DependsOnACE2AndTMPRSS2 #Blocked #ClinicallyProv…https://t.co/jwJxxs1iX7
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
6. We cited a paper by Hoffmann et al finding that #SARSCoV2 cell entry is dependent on #ACE2 and #TMPRSS2. TMPRSS2 and ACE2 are also required for #SARSCoV cell entry. https://t.co/oCy5YbW5yh
RT @biolution_net: Very happy that György Keseru of Hungarian Academy of Sciences used our #SARSCOV2 at yesterdays talk for "Celebration of…
RT @biolution_net: Very happy that György Keseru of Hungarian Academy of Sciences used our #SARSCOV2 at yesterdays talk for "Celebration of…
Very happy that György Keseru of Hungarian Academy of Sciences used our #SARSCOV2 at yesterdays talk for "Celebration of Hungarian Science" #research #covid19 #scicomm https://t.co/igCQUig0UG
RT @influenzer3: →camostat mesylateのSARS-CoV-2に対する基礎実験は｢Cell｣に掲載されています。 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by…
RT @influenzer3: →camostat mesylateのSARS-CoV-2に対する基礎実験は｢Cell｣に掲載されています。 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by…
RT @influenzer3: →camostat mesylateのSARS-CoV-2に対する基礎実験は｢Cell｣に掲載されています。 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by…
RT @influenzer3: →camostat mesylateのSARS-CoV-2に対する基礎実験は｢Cell｣に掲載されています。 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by…
RT @influenzer3: →camostat mesylateのSARS-CoV-2に対する基礎実験は｢Cell｣に掲載されています。 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by…
→camostat mesylateのSARS-CoV-2に対する基礎実験は｢Cell｣に掲載されています。 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/eH4Jd06naM
Sars 2 Trump https://t.co/ZxuEflFgvl
RT @biolution_net: the subtitles to our #SARScov2 #covid19 vids are now available also in #hungarian! #3drender #research https://t.co/Z49…
the subtitles to our #SARScov2 #covid19 vids are now available also in #hungarian! #3drender #research https://t.co/Z4949S0U5m
@Krolli5 @flavinkins @BillyBostickson https://t.co/gPyTlQNMXc https://t.co/DEyLuru84j https://t.co/QzJZqVRdK0
RT @chosi01: https://t.co/xnzH2u0b4g Los que se meten testosterona estan fritos, y parece que tener menos huevos tiene sus ventajas. Con ta…
Sars https://t.co/QuNCEuEQmm
RT @chosi01: https://t.co/xnzH2u0b4g Los que se meten testosterona estan fritos, y parece que tener menos huevos tiene sus ventajas. Con ta…
RT @chosi01: https://t.co/xnzH2u0b4g Los que se meten testosterona estan fritos, y parece que tener menos huevos tiene sus ventajas. Con ta…
https://t.co/xnzH2u0b4g Los que se meten testosterona estan fritos, y parece que tener menos huevos tiene sus ventajas. Con tal que los urologos no empiecen a ofrecer la Orquiectomia profilactica. Cortarte los huevos capaz sea mas efectivo que meterle Ivermectina.
#Sars 9 https://t.co/MokE6VwaYh
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
RT @suzuki_takaya: （ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさん…
（ナファモスタットはどうなった？） ・ナファモスタット（フサン）は膵炎の治療で日本で認可されていて、理論的にはACE2やTMPRSS2もブロックするので効きそうだし、In vitroでもそれがわかったので論文になった。でも結局患者がたくさんいなかったので試せなかった。https://t.co/hqkM3fezg8
Last but not Least Sars 8 https://t.co/TWpglQz5HI
Sars from the bottom up https://t.co/TWpglQz5HI
Coronavirus SARS-CoV-2 structure https://t.co/TNXeFuUoaw via @YouTube
What we stated for SARS is also relevant for SARS-COV-2, as they so similar to each other (refer below): SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: https://t.co/WBWaLOOpZm
What we stated for SARS is also relevant for SARS-COV-2, as they so similar to each other (refer below): SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: https://t.co/WBWaLOOpZm
What we stated for SARS is also relevant for SARS-COV-2, as they so similar to each other (refer above): SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: https://t.co/WBWaLOOpZm
What we stated for SARS is also relevant for SARS-COV-2, as they so similar to each other (refer below): SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: https://t.co/WnUU9BTuNt https://t.co/Uu4qNCNr8W https://t.co/NU92t3YTIZ
What we stated for SARS is also relevant for SARS-COV-2, as they so similar to each other (refer below): SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: https://t.co/WnUU9BTuNt https://t.co/ESHSRMFlVs https://t.co/fhGlfYuVAY
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/WnUU9BTuNt https://t.co/UaxKK0DVqx
Sars https://t.co/OoKyEyCiaz
Furthermore from purely mechanistic reasoning in vivo SARS-CoV-2 entry overwhelmingly occurs through the plasma membrane, not the endocytic pathway which renders it inured to HCQ's MoA. https://t.co/3pbLYqF2Sn
@gchwood @thecloudwizard @JohnFromCranber @GMA @GStephanopoulos SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Our results reveal important commonalities between SARS-CoV-2 and SARS-CoV infection and identify a potential target for antiviral intervention https://t.co/LRzv86UAvx
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/jpYW9cQHIP https://t.co/pK2nG7TaRD
#Sars 7 https://t.co/BGC2sSd5qH
@ne02012 @XtinaScott @drphiliplee1 In their April study doi: 10.1016/j.cell.2020.02.052, Hoffman et al. only showed the inhibition of TMPRSS2 and CatB/L blocks infection in Cacao-2 cells & 293T cells transfected to express ACE2 that enabled S protein-driven entry.
@__ice9 https://t.co/Ac077gW4vT
#SARS_CoV_2 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor featured on the @ResearchGate #COVID19 community page. Read it here: https://t.co/eWr1hCtgC8
@ne02012 @JayCampbell333 I suggest you read both studies by Hoffman et al. before you arrive at hastily drawn conclusions. The study you referenced by Hoffman et al. on TMPRSS2 was published in Feb. Cell. 2020;181(2):271-280.e8. doi:10.1016/j.cell.2020.02.052
https://t.co/rM95zp1XQK
RT @BillyBostickson: Some good news for a change SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Pr…
RT @BillyBostickson: Some good news for a change SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Pr…
RT @BillyBostickson: Some good news for a change SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Pr…
RT @BillyBostickson: Some good news for a change SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Pr…
Some good news for a change SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/GuXgUxM9H5
#Sars 4 https://t.co/oniIjAGEfA
Sars https://t.co/QfkS0TCMyw
REFERÊNCIAS 1 - [https://t.co/mY4xTDmy2F] 2 - [https://t.co/9THdivG0kp] 3 - [https://t.co/CKJ7qcVLDX] 4 -[https://t.co/rg7nSXKvGE] 5 - [https://t.co/wgS033Yoak] 6 - [https://t.co/ZQNld59jS0] 7 - [https://t.co/n2m3MHAUgV] 8 - [https://t.co/5tXiZCiGFi]
¿En qué va eso del uso de inhibidores de la TMPRSS2 contra el COVID-19? Cuenten. https://t.co/ASe5PGlDUS
Sars Channel https://t.co/MnnyKNul7F
Sars https://t.co/22CQV1Iwlv
RT @Albauser1: https://t.co/M3icNLi8dW Has there been a treatment all along? #coronavirus
https://t.co/M3icNLi8dW Has there been a treatment all along? #coronavirus
Sars https://t.co/mMNkB4hsr2
Sars https://t.co/P84lpcURcQ
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a ... https://t.co/AJFt5puCNH
#Sars https://t.co/LX4TL9NroY
#Sars II nr 5 https://t.co/mE9O7Qh9bF
Sars https://t.co/pVk7Xr0Rfz
Sars from the bottom up https://t.co/F4hpYXYSph
@yletiede @KariTikkinen "SARS 1 and #Covid_19 spike protein : SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. https://t.co/roFO2YRbPr
@JuhaniKnuuti @risto_kuosa SARS 1 and #Covid_19 spike protein : SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. https://t.co/roFO2YRbPr
#Sars https://t.co/xHXoMsBDGe
今週のJCは5月28日午後5時からZOOMにて。 タイトルはSARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. Cell 181,271–280,2020 https://t.co/ypV1DXT5ZM です。参加希望者は下記まで（HA）。 asao-h@med.id.yamagata-u.ac.jp
SARS 1 and #Covid_19 spike protein : SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. https://t.co/roFO2YRbPr
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/xKoxHt7hpE
RT @InHouseDoc: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/t…
Sars 2 https://t.co/wv5EJb6GpU
おすすめコロナウイルス論文その１ SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor 4月16日にドイツなどから出た論文
#Sars nr 2 https://t.co/OfLlYMtohl
In case someone missed this important piece of information: not only ACE-2 is important. SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a ... https://t.co/f7HL4ykxyl
#fauci @fauci @drsanjaygupta .. “SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor [*]” Markus Hoffmann et al. (16 April, 2020, doi:10.1016/j.cell.2020.02.052) ..
読み物: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: https://t.co/Z8elFuuRDo
RT @jquinteromd: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/PL…
#Sars nr 7 https://t.co/1Hkibhq2SZ
RT @jquinteromd: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/PL…
備忘録フサン・フォイパン関連の文献 SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor | https://t.co/G5bl8EwxFD
@EricBillyFR @FZores @Le___Doc @ElVeider_FDV @fluidloading @Damkyan_Omega https://t.co/iIT1OkxWW9
https://t.co/Fq9q1TTRu3
Good News ✨
Coronavirus SARS-CoV-2 structure https://t.co/r5dogOf4A7
RT @KFSHRC_Research: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.c…
RT @KFSHRC_Research: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.c…
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/7sZLcYZczr https://t.co/Duzy7bw2Sb
Fantastic animated video by @biolution_net ⤵️ #SARSCoV2 structure and infection https://t.co/tUzOfmyLIV
＞3月5日付で生物医学専門誌『cell』のサイトで公表された論文「SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor」 https://t.co/XennXChDch に、内田医師は注目した
#Sars nr 10 https://t.co/XBfRSgJFSv
@realDonaldTrump @TomTiffanyWI https://t.co/XGKWGE30zQ
@realDonaldTrump https://t.co/XGKWGE30zQ
@htTweets @HTTech https://t.co/XGKWGE30zQ
https://t.co/XGKWGE30zQ
RT @litcovid_nyu: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor High Yield Po…
RT @basakdr: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/rjeRAy…
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/rjeRAyTV23
RT @litcovid_nyu: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor High Yield Po…
RT @EdnaMattaC: "This study provided key insights into the first step of SARS-CoV-2 infection, viral entry into cells, and defined potentia…
RT @TUK_MBN: Hey I was just watching this video on coronavirus and it explain what it was made up of. Is it possible that this was a Biowea…
RT @EdnaMattaC: "This study provided key insights into the first step of SARS-CoV-2 infection, viral entry into cells, and defined potentia…
"This study provided key insights into the first step of SARS-CoV-2 infection, viral entry into cells, and defined potential targets for antiviral intervention." #Covid_19
RT @biolution_net: Within 25 days our first
Hey I was just watching this video on coronavirus and it explain what it was made up of. Is it possible that this was a Bioweapon created by China that had a outbreak? https://t.co/rh25xVLoFw
To share a new paper on treatment of COVID-19. I suppose SARS-Cov-2 binding to ACE2 explains to a large extent the pulmonary manifestations SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/WYxZcOuM1d
@PghCurrent @billpeduto @CulturalTrust Finally, camostat mesylate looks promising; https://t.co/L6LfxhoKvE
However, the strong consensus from multiple labs and rigorous experiments is that ACE2 and TMPRSS2 are the key membrane-associated proteins/proteases facilitating viral entry of SARS-CoV-2, and not human DPP4 https://t.co/uNVQhWuyJK
RT @litcovid_nyu: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor High Yield Po…
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor High Yield Points * Camostat mesylate (protease inhibitor) inhibits TMPRSS = partially blocked viral entry * In vitro study Review by Charles Ng https://t.co/MoXdDQb3A6 https://t.co/3rhQtiKswF
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. https://t.co/loqJzDyKAE https://t.co/a89DawsGIG
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
Transmembrane proteaz serin 2 virusun spike proteininin ACE-2 ile etkileşimini tetikleyen bir proteaz ve bu molekülün inhibsyonunun yeni bir tedavi yaklaşımı oluşturabileceği söyleniyor. Şu makale: https://t.co/uIwdm4R3C5 okuyunuz, okutunuz #vaka52167
Preventing spread of SARS coronavirus-2 in humans https://t.co/XOBq25zAzT via @YouTube
Coronavirus SARS-CoV-2 structure https://t.co/enM4mZlv8B via @YouTube
RT @Charles27710945: Coronavirus SARS-CoV-2 structure https://t.co/9Mo4KU6iif vía @YouTube
Coronavirus SARS-CoV-2 structure https://t.co/9Mo4KU6iif vía @YouTube
Coronavirus SARS-CoV-2 structure https://t.co/y51G5OXsUV via @YouTube Visit https://t.co/X6HUOniPOB to find Bio-Medical ideas that aid in understanding the mechanism of infectious diseases, including SARS-COV1/2 https://t.co/yZq5qknKUQ https://t.co/VlsjXHd0Oj
#كورونا #كوفيدا_19 شكل ثلاثي الأبعاد لفيروس #SARSCoV2 Coronavirus SARS-CoV-2 structure https://t.co/IPZGqmHgbr via @YouTube https://t.co/H38yl2YBNi
SAR-COV2 structures https://t.co/gnzK97lMQG
RT @biolution_net: Within 25 days our first
Within 25 days our first
SARS-COV2 Structure https://t.co/9pqzeqt9gd
@kevinnbass ...https://t.co/1XfXuAqHNA https://t.co/vSseXMjZOL Not sure why the links aren’t populating. Nonetheless....
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/rXFu3V1s3g
RT @Lalaatlarge: Hope ? #covid19 #coronavirus #hopes #sarscov2 #ACE2 #cell # #epidemic # #drugdiscovery #repurposing #LinkedIn 230 https:…
RT @Lalaatlarge: Hope ? #covid19 #coronavirus #hopes #sarscov2 #ACE2 #cell # #epidemic # #drugdiscovery #repurposing #LinkedIn 230 https:/…
Coronavirus SARS-CoV-2 structure https://t.co/cXeVzS1ZI2 vía @YouTube
Hope ? #covid19 #coronavirus #hopes #sarscov2 #ACE2 #cell # #epidemic # #drugdiscovery #repurposing #LinkedIn 230 https://t.co/RpiNfyWuXk https://t.co/v0SswCWXLo
Hope ? #covid19 #coronavirus #hopes #sarscov2 #ACE2 #cell # #epidemic # #drugdiscovery #repurposing #LinkedIn 230 https://t.co/pWU8S7WZLK
@_musang_gala @jasonhaw_ @threadreaderapp other journal article reveal that SARS-CoV-2 cell entry is dependent on two (2) enzyme receptors: 1) ACE2, and 2) TMPRSS2 SOURCE: "SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor" https://t.co/dYPDj3Rnyt
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/E3WzpR8vIH
Coronavirus SARS-CoV-2 structure https://t.co/QrVuVQXmt1 via @YouTube
@andy_utoronto @jwoodgett For knockdown, TMPRSS2 may be worth considering rather than ACE2: e.g. https://t.co/xcbINdyKHW, https://t.co/puYPqgCU6h, https://t.co/218iRrhJqp
If anyone is interested n the science of corona family viruses, this is an interesting read. https://t.co/JoRftcCPku
Camostat is used in Japan to treat pancreatic inflammation and is inhibitor of TMPRSS2. In article published in cell, camostat and nafamostat worked invitro to prevent entry of virus in cell. (DOI:https://t.co/AcOMIgsCL3) https://t.co/lhxmOobRpj
RT @BertrandBio: new interesting trial starting Denmark, testing #ONO's camostat mesilate (FOIPAN), a TMPRSS2 inhibitor in #covid19 patient…
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/4tLeqAqJjj
@Mar12tas Tak už asi měsíc se ví, že camostat, což je inhibitor proteázy, do jisté míry potlačuje infekci koronaviru. Jde ale o buněčné kultury, to ještě potrvá. Momentálně se testuje spousta podobných léků na něco jiného, co by mohlo fungovat. https://t.co/ZKatrJBVmQ
One for the fellow geeks. I did not know that coronavirus uses host membrane for the envelope. Slippery sod. https://t.co/3DvAaFotXu
https://t.co/fnrm2j8Wsl Video con información del Covid 19, Pueden poner subtitulos / Video with Covid 19 information, You can put the subtitles / Vidéo avec des informations du Covid 19. Ils peuvent activer les sous-titres
SARS-CoV-2 infection depends on the host cell factors ACE2 and TMPRSS2 and can be blocked by a clinically proven protease inhibitor. https://t.co/eHQSP0x4Vl https://t.co/nugbXbWaTf
2/ With increased prostate activity, and cancer, massive unregulated proteases. Block the protease or decrease it, block the virus (yet another similarity between virus & cancer). https://t.co/XLn1k7a2sD
Coronavirus SARS-CoV-2 structure https://t.co/9AXKb7JYQP #coronavirus #COVID19mexico #3D
@Docpinel https://t.co/RRoNuZb88Y
RT @biolution_net: Within 10 days our #corona video hit 100k views and the intrest for scientific information remains intense. Thanks @yout…
RT @trotmanlab: Amazing data on gender differences. TMPRSS2 is essential for CoV-2 entry. Its levels may be higher in lungs of men. https:/…
RT @BertrandBio: new interesting trial starting Denmark, testing #ONO's camostat mesilate (FOIPAN), a TMPRSS2 inhibitor in #covid19 patient…
RT @mmalken: المصادر ١- https://t.co/Hld3mjTp8o... ٢- https://t.co/Y5yWCgQVfY ٣- https://t.co/2k2ooxG78W ٤- https://t.co/GaDCFsmWAA
RT @Medillustrates: *Coronavirus SARS-CoV-2 Structure* by medical animation studio @biolution_net View More: https://t.co/aGSqtNlmer #cov…
*Coronavirus SARS-CoV-2 Structure* by medical animation studio @biolution_net View More: https://t.co/aGSqtNlmer #covid19 #SARS_CoV_2 #coronavirus #pandemic https://t.co/FdY4C4ynBr
المصادر ١- https://t.co/Hld3mjTp8o... ٢- https://t.co/Y5yWCgQVfY ٣- https://t.co/2k2ooxG78W ٤- https://t.co/GaDCFsmWAA
Good visualization and summary of Coronavirus SARS-CoV-2 structure and mechanism: https://t.co/jDZqKiDoR1
RT @BertrandBio: new interesting trial starting Denmark, testing #ONO's camostat mesilate (FOIPAN), a TMPRSS2 inhibitor in #covid19 patient…
RT @BertrandBio: new interesting trial starting Denmark, testing #ONO's camostat mesilate (FOIPAN), a TMPRSS2 inhibitor in #covid19 patient…
new interesting trial starting Denmark, testing #ONO's camostat mesilate (FOIPAN), a TMPRSS2 inhibitor in #covid19 patients SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/1QXJheGBhd https://t.co/JxlfI48aUW
Preventing spread of SARS coronavirus-2 in humans https://t.co/YkUjffZrGm via @YouTube
RT @docmmiller: Yes the dipeptidase ACE2 as well as similar proteases appear to affect #coronavirus docking. A recent report with an approv…
RT @DrZoeHyde: @noawitheringly @Spiritism00 Good point. Thank you for the clarification. Yes, better to say that ACE2 is being used as a re…
RT @GCChemosensoryR: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: Cell #COVI…
RT @DrZoeHyde: @noawitheringly @Spiritism00 Good point. Thank you for the clarification. Yes, better to say that ACE2 is being used as a re…
RT @DrZoeHyde: @noawitheringly @Spiritism00 Good point. Thank you for the clarification. Yes, better to say that ACE2 is being used as a re…
@noawitheringly @Spiritism00 Good point. Thank you for the clarification. Yes, better to say that ACE2 is being used as a receptor for the virus. https://t.co/tOskAFHt72
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: Cell @evrimagaci bunu değerlendirebilir misiniz önemli bir adım mı https://t.co/VpmWQM2Xcm
RT @trotmanlab: Amazing data on gender differences. TMPRSS2 is essential for CoV-2 entry. Its levels may be higher in lungs of men. https:/…
Amazing data on gender differences. TMPRSS2 is essential for CoV-2 entry. Its levels may be higher in lungs of men. https://t.co/PMy1PhSDUB https://t.co/HTasZ6uCfX
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor https://t.co/5rzVqZfBqx
RT @DanielleRReed: Serine protease TMPRSS2 primes SARS-CoV-2 for entry into human cells @MonellSc https://t.co/jDRlBqmcSY
RT @DanielleRReed: Serine protease TMPRSS2 primes SARS-CoV-2 for entry into human cells @MonellSc https://t.co/jDRlBqmcSY
RT @GCChemosensoryR: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: Cell #COVI…
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor: Cell #COVID19 https://t.co/xhJTiExmbm
Serine protease TMPRSS2 primes SARS-CoV-2 for entry into human cells @MonellSc https://t.co/jDRlBqmcSY
RT @PENNCoV: Cell paper identifies ACE2 receptor for SARS-CoV-2 viral entry, highlights role of protease TMPRSS2, and identifies similariti…
RT @PENNCoV: Cell paper identifies ACE2 receptor for SARS-CoV-2 viral entry, highlights role of protease TMPRSS2, and identifies similariti…
RT @PENNCoV: Cell paper identifies ACE2 receptor for SARS-CoV-2 viral entry, highlights role of protease TMPRSS2, and identifies similariti…
RT @PENNCoV: Cell paper identifies ACE2 receptor for SARS-CoV-2 viral entry, highlights role of protease TMPRSS2, and identifies similariti…
Cell paper identifies ACE2 receptor for SARS-CoV-2 viral entry, highlights role of protease TMPRSS2, and identifies similarities to SARS-CoV #Covid19 #coronavirus https://t.co/Vb78bNGxUS
RT @medpedshosp: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - Camostat. #CO…
RT @medpedshosp: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - Camostat. #CO…
RT @medpedshosp: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - Camostat. #CO…
RT @medpedshosp: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - Camostat. #CO…
RT @medpedshosp: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor - Camostat. #CO…
@pineda_602 10.1016/j.cell.2020.02.052
RT @Medillustrates: *SARS-CoV-2 scientific animation based on structural data* by medical animation studio Biolution GmbH. View Biolution'…
RT @Medillustrates: *SARS-CoV-2 scientific animation based on structural data* by medical animation studio Biolution GmbH. View Biolution'…
*SARS-CoV-2 scientific animation based on structural data* by medical animation studio Biolution GmbH. View Biolution's portfolio: https://t.co/g7Err4Rbu0 #coronavirus #worldhealthorganization #covid19 #medicalanimation #medicalresearch https://t.co/WLOELV0zJY
RT @neXtProt_news: @egonwillighagen @ISBSIB @s_sommaruga @alain_berset @uniprot @GlycomicsExpasy @nextprot @lydie_lane Search for coronavir…
@egonwillighagen @ISBSIB @s_sommaruga @alain_berset @uniprot @GlycomicsExpasy @nextprot @lydie_lane Search for coronavirus https://t.co/qz1e90uLk1 returns 117 results, including ACE2 and TMPRSS2 that #COVIDー19 depends on to enter the cell https://t.co/6eolydaYGn https://t.co/dROTlEEOg6
@youtube is supporting credible and HQ information about #covid19 with excellent measures: limited advertisement; only trusted sources receive "browse features" impressions and @WHO link under each vid
RT @biolution_net: Within 10 days our #corona video hit 100k views and the intrest for scientific information remains intense. Thanks @yout…
RT @biolution_net: Within 10 days our #corona video hit 100k views and the intrest for scientific information remains intense. Thanks @yout…
RT @biolution_net: Within 10 days our #corona video hit 100k views and the intrest for scientific information remains intense. Thanks @yout…
Within 10 days our #corona video hit 100k views and the intrest for scientific information remains intense. Thanks @youtube limit advertisement and browse features only to official info sources #SARSCoV2 #Covid_19
Some news from the infectious disease biologists. In vitro, but a potential line of attack: SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor. https://t.co/qt8xEp7sC6
RT @biolution_net: Acabamos de actualizar nuestro nuevo video sobre el Coronavirus #COVID19 con subtitulos en español! Míralo aqui: https:/…
Coronavirus SARS-CoV-2 structure https://t.co/LjDcTXnxdG via @YouTube
@realDonaldTrump anyone seen this study ? https://t.co/hS5qTO29d1
Hoffmann et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell (2020), https://t.co/7KI9fSUgEn https://t.co/Wtt7zG21QV
@MattHancock Research just out: Hoffmann et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a ClinicallyProven Protease Inhibitor, Cell (2020), https://t.co/NffaTiRbOC
@uksciencechief Just out: Hoffmann et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a ClinicallyProven Protease Inhibitor, Cell (2020), https://t.co/NffaTiRbOC
@CMO_England Out today: Hoffmann et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a ClinicallyProven Protease Inhibitor, Cell (2020), https://t.co/NffaTiRbOC
RT @sciencecohen: There's a good deal of overlap in infection process. See these papers: https://t.co/dpXwG9gqYA and https://t.co/zEiRbnY…
RT @sciencecohen: There's a good deal of overlap in infection process. See these papers: https://t.co/dpXwG9gqYA and https://t.co/zEiRbnY…
There's a good deal of overlap in infection process. See these papers: https://t.co/dpXwG9gqYA and https://t.co/zEiRbnYLdl https://t.co/rlGA63ihPX
vía: Hoffmann et al., SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor, Cell (2020), https://t.co/0yZzoMjuxe
Cc @chavena_fria RT @LuisMateusRocha: Science to the Rescue! #COVID2019 (link to text as pdf link does not always work: https://t.co/96XrIDbqUG) https://t.co/VUFWBpPk6A
Los anticuerpos de infecciones por otros coronavirus menos letales (SARS) dan protección contra el COVID-19 humano pandemico, por ende sueros de estos pacientes pueden ser usados como barrera para frenar al COVID19 https://t.co/j9SCTNaOg3. https://t.co/fIr0s1npG1
RT @docmmiller: Yes the dipeptidase ACE2 as well as similar proteases appear to affect #coronavirus docking. A recent report with an approv…
One step ahead. #SARS-CoV-2 uses #ACE2 receptor for host cell entry, and spike protein of SARS-CoV-2 primed by #TMPRSS2 https://t.co/MKYx60Jwzu https://t.co/3HrNZCw9Wm
También se propone el uso de Camostat, droga que al parecer bloquea la entrada dependiente de ACE2 y TMPRSS2 (https://t.co/fEdGK1NS1T). Esta droga también previene muerte en ratones con SARS-CoV-1 y en Japón fue aprobada para su uso en pancreatitis. https://t.co/CcAQngbUqW
Preventing spread of SARS coronavirus-2 in humans https://t.co/ArrcgnftrY via @YouTube
#Japan #COVIDー19 #CamostatMesylate #camostatMesilate https://t.co/AhGDQX2RJR
SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor M. Hoffmann, H. Kleine-Weber, ..., C. Drosten, and S. Pohlmann Cell 181, 1–10, April 16, 2020 https://t.co/WJG704mOuo
@EricTopol @jclinicalinvest @ACasadevall1 @JohnsHopkinsSPH @EinsteinMed ... SARS-CoV S mouse polyclonal sera potently inhibited entry into target cells of SARS-CoV-2 S pseudotyped viruses ... Cell 03-09 https://t.co/BAwFWg3Rpu ... sera from convalescent SARS patients cross-neutralized SARS-2-S-driven entry ... Cell 03-05 https://t.co/akSWK6AsJR
RT @bioBlogia: #SARSCov2 usa el receptor ACE2 para infectar las células blanco. Tanto inhibidores clínicamente probados de la proteasa TMPR…
RT @bioBlogia: #SARSCov2 usa el receptor ACE2 para infectar las células blanco. Tanto inhibidores clínicamente probados de la proteasa TMPR…
#SARSCov2 usa el receptor ACE2 para infectar las células blanco. Tanto inhibidores clínicamente probados de la proteasa TMPRSS2 como anticuerpos de personas infectadas resultaron exitosos en bloquear la infección viral #Cell #Coronavirus #CoVid19 https://t.co/7EoxhyX7Gp
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
Preventing spread of SARS coronavirus-2 in humans https://t.co/wl28LVRfU2 via @YouTube
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
Preventing spread of SARS coronavirus-2 in humans https://t.co/zTZQdoULPi via @YouTube
Behinderung von SARS-CoV-2 beim Eindringen in Lungenzellen über TMPRSS2 / ACE2 . Das Paper der deutschen Wissenschaftler bei CELL: https://t.co/Wr012dVpPH
RT @DrBeat019: @FYang_EP @GileadSciences Preventing spread of SARS coronavirus-2 in humans https://t.co/xXTH1gHO95 via @YouTube
@FYang_EP @GileadSciences Preventing spread of SARS coronavirus-2 in humans https://t.co/xXTH1gHO95 via @YouTube
RT @docmmiller: Yes the dipeptidase ACE2 as well as similar proteases appear to affect #coronavirus docking. A recent report with an approv…
RT @docmmiller: Yes the dipeptidase ACE2 as well as similar proteases appear to affect #coronavirus docking. A recent report with an approv…
RT @docmmiller: Yes the dipeptidase ACE2 as well as similar proteases appear to affect #coronavirus docking. A recent report with an approv…
Yes the dipeptidase ACE2 as well as similar proteases appear to affect #coronavirus docking. A recent report with an approved drug in Japan was also encouraging & may be therapeutic Hoffmann, M et al. Cell doi:10.1016/j.cell.2020.02.052. https://t.co/cn7XLIqsJF
Preventing spread of SARS coronavirus-2 in humans #Covid19 #coronavirus #camostat https://t.co/ppLVxkgrEL via @YouTube
RT @DraganaObrado20: SARS-CoV2/COVID19 uses SARS-CoV receptor ACE2 for host cell entry
One potential compound to stop the SARS-CoV-2 infecting lung cells - in vitro #COVIDー19 @DPZ_eu https://t.co/v2GUMSh8tH
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @DraganaObrado20: SARS-CoV2/COVID19 uses SARS-CoV receptor ACE2 for host cell entry
RT @DraganaObrado20: SARS-CoV2/COVID19 uses SARS-CoV receptor ACE2 for host cell entry
SARS-CoV2/COVID19 uses SARS-CoV receptor ACE2 for host cell entry
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @SaudiVirologist: شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41q…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @SaudiVirologist: شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41q…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically-proven protease inhibitor. #SARSCoV2 #COVID19 Hoffmann, M et al. Cell (2020). DOI: 10.1016/j.cell.2020.02.052 https://t.co/vaytEqlRxd https://t.co/60HK5DT6pz
RT @SaudiVirologist: شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41q…
RT @SaudiVirologist: شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41q…
RT @SaudiVirologist: شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41q…
RT @SaudiVirologist: شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41q…
#CoronavirusOutbreak BREAKING!!! The drug #Camostat could possibly be used to stop the spread of #COVID19. https://t.co/snUcEWIENf
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @KnighsTalker: #Coronavirus BREAKING!!! The drug #Camostat_mesilate could possibly be used to stop the spread of COVID-19. https://t.co/…
RT @KnighsTalker: #Coronavirus BREAKING!!! The drug #Camostat_mesilate could possibly be used to stop the spread of #COVID19. https://t.co/…
RT @KnighsTalker: #CoronavirusOutbreak BREAKING!!! The drug #Camostat_mesilate could possibly be used to stop the spread of #COVID19. https…
#CoronavirusOutbreak BREAKING!!! The drug #Camostat_mesilate could possibly be used to stop the spread of #COVID19. https://t.co/snUcEWIENf
#Coronavirus BREAKING!!! The drug #Camostat_mesilate could possibly be used to stop the spread of #COVID19. https://t.co/snUcEWIENf
RT @SaudiVirologist: شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41q…
#Coronavirus BREAKING!!! The drug #Camostat_mesilate could possibly be used to stop the spread of COVID-19. https://t.co/snUcEWIENf
شرح لكيفية استخدام مركب TMPRSS2 Inhibitor كمضاد ل #فيروس_كورونا_سارس2 وبالتالي إيقاف انتشار الفيروس https://t.co/41qoAYOctl https://t.co/CqCd6HvA9C https://t.co/FbhpuTFvvH
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @Mitominder: A quien le interesa: Originalpublikation Hoffmann, M et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @DPZ_eu: Interview with Stefan Pöhlmann on how the attachment protein (spike) of the new coronavirus #SARSCoV2 uses the cellular attachm…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @Mitominder: A quien le interesa: Originalpublikation Hoffmann, M et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and…
A quien le interesa: Originalpublikation Hoffmann, M et al. (2020). SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a 2 clinically-proven protease inhibitor. Cell, DOI: 10.1016/j.cell.2020.02.052
RT @DPZ_eu: Interview with Stefan Pöhlmann on how the attachment protein (spike) of the new coronavirus #SARSCoV2 uses the cellular attachm…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @DPZ_eu: Interview with Stefan Pöhlmann on how the attachment protein (spike) of the new coronavirus #SARSCoV2 uses the cellular attachm…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
RT @CaKizil: Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkin…
Korona virüsünün hücreye girmesinde rol alan ACE2 proteinine ek olarak virüsün enfeksiyon etkisini başlatan S proteinini etkinleştiren TMPRSS2 enzimini bloke etmenin yoluyla ilgili bir yayın biraz önce yayınlandı. Bu hastalığı anlamada çok önemli bir adım https://t.co/bRClNj6fUd
RT @DPZ_eu: Interview with Stefan Pöhlmann on how the attachment protein (spike) of the new coronavirus #SARSCoV2 uses the cellular attachm…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @DPZ_eu: Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_…
RT @DPZ_eu: Interview with Stefan Pöhlmann on how the attachment protein (spike) of the new coronavirus #SARSCoV2 uses the cellular attachm…
Interview with Stefan Pöhlmann on how the attachment protein (spike) of the new coronavirus #SARSCoV2 uses the cellular attachment factor (ACE2) and the cellular protease TMPRSS2 for its activation. https://t.co/0oSFG5BxdN
Preventing spread of #SARS #coronavirus 2 in humans - our infection biologists identified potential drug @ChariteBerlin @DZIF_ https://t.co/0oSFG5BxdN https://t.co/eERzg2cwU9
@vickyyyf @angie_rasmussen @CellCellPress Great reporting. Thx for finding the @CellCellPress paper (will be https://t.co/QkxqBRr9w1). A common theme: #chloroquine, #remdesivir, and #camostat all block #COVID19 #coronavirus in cells, and worked against the related SARS-CoV in mice in earlier studies. Past work pays off!
#DrHabib_Covid19_Updates There Is A Drug Already Used In Japan Which May Treat COVID-19 By: Victoria Forster For more details: =Solidarity with Japan= https://t.co/sF9yVcuJx2 Journal pre-proofDOI: 10.1016/j.cell.2020.02.052 Thi…https://t.co/vkcXKSC3OU https://t.co/PWQrxQVZnA
@JahodaLubos @ErikMoravia @AndrejBabis Kdyz vezmete svou predstavu, co znamena "pod kontrolou" a verite, ze takovy to ma vyznam, tak verim, ze z Vaseho pohledu vypadam mimo. V cem je tenhle test "vysoce nespolehlivy"? https://t.co/bfmbGiTK9o Pripada Vam tohle jako "vubec nic"? DOI: 10.1016/j.cell.2020.02.052
NO
KU
MM
AW